New guidelines on the care of severe premenstrual syndrome are issued today.
The advice from the Royal College of Obstetricians and Gynaecologists updates previous guidelines from 2007.
It explains that the timing of symptoms and degree of impact on daily activity determines a diagnosis of severe premenstrual syndrome.
Women with the condition suffer symptoms including depression, anxiety, irritability, loss of confidence and mood swings, as well as physical symptoms such as bloating and breast pain.
Severe premenstrual syndrome can be diagnosed if this is severe enough to impact on daily activity or interfere with work, school performance or relationships.
Specific symptom diaries are used in the first instance, then a medication which switches off ovarian production of oestrogen, progesterone and testosterone called GnRH analogue can be taken so that other psychiatric disorders can be ruled out.
Treatment may include the contraceptive pill (without monthly breaks), selective serotonin reuptake inhibitors, oestrogen patches or an implant, cognitive behavioural therapy, vitamin B6 supplements, or exercise. Hysterectomy may be offered as a last resort, and offers a permanent cure.
Co-author, Professor Shaughn O’Brien of Keele University, UK, says: "Premenstrual syndrome can be a serious condition which can dramatically impact on the quality of a woman’s life affecting her personal and professional life. In the most extreme cases, premenstrual syndrome can lead to self-harm and suicide.
"We hope that these guidelines go some way in raising awareness of the seriousness of the condition and available treatment options, not only in women but also among healthcare professionals."
Leave a Reply